Daily activities like walking, going to the store, or climbing stairs can be challenging for persons with angina and heart failure. For patients with cardiac disease, a non-invasive procedure called EECP may be employed. It has been clinically proven to be secure and efficient in the treatment of angina and heart disease. Compared to other treatments like stents or bypass surgery, this one may offer more relief.
What Is The EECP Treatment?
The EECP was launched in 1960. Its goal is to enhance the amount of blood returning to the heart. The heart can function more effectively as a result. The US FDA and NHS UK have both given their approval to the EECP treatment for heart disease patients. Since then, there have been many installations all throughout the world.
Cost Effective
In comparison to Bypass Surgery or Stents, it is more affordable.
US-FDA Approved
The US-FDA Approved has received approval from the most prestigious body in the world.
Operation-Free
Operation-Free – There is no discomfort associated with this non-surgical procedure.
No negative effects
Patients experience increased alertness and vigour following each session; there are no negative effects.
How does EECP Treatment works?
While the heart is at rest, EECP treatment pumps blood from the legs to the heart. It promotes angiogenesis and improves blood circulation throughout the body.
The EECP machine is made to provide comfort for patients within a 1-hour period. The bed is curved and moldy to comfort the patient's body to relax muscles.
The calves, thighs, and buttocks are wrapped with three large cuffs. These cuffs attach to the machine and synchronize with the patient's heartbeat.
An EECP machine with three lead ECGs is attached to the patient. The ECG feeds into a machine that works according to the patient's instructions during treatment.
These cuffs inflate and deflate sequentially during the treatment. They squeeze the calves, buttocks, and thighs to the beat of the heart, while not interfering or interfering with the body’s natural functions
OUTSIDE COUNTERPULSATION
- For patients with IHD (ischemic heart disease), such as angina or heart failure, it is fully safe and non-surgical.
- By allowing Micro vessels (Collaterals) within the Coronary Arteries to expand and build Natural Bypasses around blocked locations, EECP Treatment enhances the flow of oxygenated blood to the heart.
- Treatment for EECP typically lasts 6-7 weeks and involves 35–38 sessions.
REASONS FOR SELECTING EECP
- For individuals with heart failure, coronary artery disease, angina, and heart failure, it is the sole non-invasive therapeutic option. It might lessen or even get rid of angina pain.
- EECP can be utilized for conditions including excessive blood pressure and diabetes in addition to coronary artery disease.
- Additionally, it can provide patients greater energy and enable them to lead an active lifestyle.
THE FOLLOWING DISEASES CAN BE HELPED BY EECP TREATMENT FOR PATIENTS.
- Chronic chest pain
- Congestive heart disease
- Hypertension
- Stroke \ Diabetes
- Coronary artery disease
- Leg ache
- kidney failure
- fatigue difficulty breathing
- Limited Circulation
- Shortness of Breath
- Sport Improvement
- Erection problems
- Longer exercise sessions and improved endurance
EECPT TREATMENT BENEFITS.
- multiplies the collateral circulation
- develops brand-new tiny blood vessels
- favours natural bypass
- arteries are renewed
- decreases arterial rigidity
- makes organ dysfunction better
- increases brain blood flow and strengthens the cardiovascular system
- lymphatic circulation is increased
- Increases nitric oxide and reverses the consequences of heart disease
- prolongs life and has anti-aging effects
- Reduces anxiety and despair and regenerates organs and tissue
EECP is a regenerative treatment.
- The medical procedure of replacing or developing human tissues, organs, or cells in order to restore normal functionality is referred to as regeneration. The NIH claims that EECP circulates endothelial progenitor cells or hematopoietic precursor cells (HPCs) (EPCs).
- The flow reversal brought on by the consecutive inflating of pneumatic cuffs during EECP Therapy increases the shear stresses at the endothelium border, which is the reason behind the rise in circulating regenerative cells.
Effect of EECP Treatment on levels of plasma endothelin-1 and nitric oxide
- Nitric oxide, the primary signaling molecule of the body, is significant. Endothelial cells that lining the arteries create it. It works to relax the arteries by penetrating the smooth muscles. Nitric oxide is crucial for maintaining healthy blood pressure and general circulation, among other things. By lowering inflammation and oxidative stressors, it aids in keeping the endothelium in its desired shape.
- The NIH study found that EECP dramatically raises diastolic blood flow. Additionally, it has been proposed that EECP might enhance endothelial function by increasing shear stress. Plasma NOx steadily rises and plasma ET-1 gradually falls during EECP therapy. This neurohormonal data is consistent with the idea that EECP improves endothelial function.
Treatment Certified By
Make An Appointment
Book your appointment by filling out below details.